General Motors Gives Up on Australia as Restructuring Continues
GM's Holden brand failed Mary Barra's capital allocation test.
This Government Contractor Can Bounce Back After Losing Its Biggest Contract
The Navy just torpedoed Perspecta's momentum. Is it time to abandon ship?
Is Inovio Pharmaceuticals a Screaming Buy?
Investors may want to think twice before buying this vaccine stock on the heels of the COVID-19 threat.
ConocoPhillips has spent the past several years building its business to thrive in a volatile oil market.
The high-end maker of rugged outdoor gear easily blew past Wall Street's forecasts.
What took it so long?
Here's one financial product that's definitely worth capitalizing on.
The Canadian cannabis producer trounced analysts' Q3 estimates. Here's how Canopy did it.
These businesses have the winning trifecta: a stable dividend, ongoing earnings growth, and attractive valuation.
Retiring super early is possible, but you'll need a smart strategy to achieve this goal.
The upside is limited for one, but the other has a big growth opportunity.
A dropped lawsuit by the biggest player in the industry removes a cloud of doubt over its future.
Like steady income? Then dividend stocks are probably a good choice for you.
Where do Social Security's asset reserves really go?
Shares of the pharmaceutical giant are down 4.3% in light of the news.
The company ventures to London to buy an asset in a lucrative, cutting-edge surgical field.
Over a three-year period, the pharmaceutical giant reported it made $278 million more than it really did.
Even with the global economy expanding almost 3%, the International Energy Agency said global emissions held steady. Separately, the agency said it expects global oil demand will fall in the first quarter of 2020.
The World Health Organization is calling it a milestone in Ebola prevention.
A Republican state senator is behind the proposed legislation.
Consumers are spending more, but not dividing up those greater outlays equally.
Consumer complaints against the teeth-aligner company have investors frowning.
American Axle notes GM work stoppage hindered fourth-quarter results -- here's what investors need to know.